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ABSTRACT
The Protein Ontology (PRO) provides a formal,
logically-based classification of specific protein
classes including structured representations of
protein isoforms, variants and modified forms.
Initially focused on proteins found in human,
mouse and Escherichia coli, PRO now includes rep-
resentations of protein complexes. The PRO
Consortium works in concert with the developers
of other biomedical ontologies and protein know-
ledge bases to provide the ability to formally
organize and integrate representations of precise
protein forms so as to enhance accessibility to
results of protein research. PRO (http://pir
.georgetown.edu/pro) is part of the Open
Biomedical Ontology Foundry.
INTRODUCTION
Biomedical ontologies have emerged as important tools
for aggregating and integrating information to facilitate
knowledge discovery in heterogeneous, genome-scale
data sets (1). Ontologies are designed to make logically
coherent connections in ways that computers can exploit
for multiple different purposes, including data retrieval,
consistency checking, integration and reasoning. In this
sense they are resources that add to the power of
traditional databases. The Gene Ontology (GO) (2),
in particular, is a widely-used standard for gene product
annotation that is now used as the basis for many different
sorts of statistical analyses of biological and clinical data.
Numerous ontologies covering a variety of biomedical
domains are currently available, and a subset of
ontology developers have committed to a collaborative
effort called the Open Biomedical Ontologies (OBO)
Foundry (3) to further these efforts in a systematic way.
We describe here the Protein Ontology (PRO). The
PRO resource leverages and adds value to existing
protein sequence resources such as UniProtKB (4) by
providing an ontological representation of proteins and
protein complexes. It presents a way to refer to these
entities, provides rigorous deﬁnitions of these terms, and
gives information concerning the relations between
them—for example subtype and derivation—along
the lines described in (5). Notably, PRO provides the
indicated information especially with respect to the
states that proteins and protein complexes can exhibit as
a result of various biological processes.
THE PRO
PRO within the OBO foundry
OBO Foundry ontologies are organized along two dimen-
sions: (i) granularity (from molecules to populations); and
(ii) relation to time (objects, qualities, processes). As an
OBO Foundry member, PRO is charged with covering the
domain of protein-related objects at the molecular level of
granularity. Speciﬁcally, PRO represents those naturally-
occurring molecules that contain amino acid chains, which
is to say: proteins, peptides produced by cleavage of longer
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from speciﬁc taxa. When appropriate, the terms in PRO
are deﬁned via cross-products using other ontology or
database resources. For example, we deﬁne mature
forms of leucoagglutinating phytohemagglutinin using
the Sequence Ontology (SO) (6) and the Protein
Modiﬁcation Ontology (PSI-MOD) (7) to provide terms
for parts of proteins removed during maturation and
modiﬁed amino acid residues, respectively. The Chemical
Entities of Biological Interest Ontology (ChEBI) (8)
likewise provides terms that are used to deﬁne those
PRO objects that contain non-protein attachments or
components. Finally, Pfam (9) provides terms used to
describe protein regions. Similarly, PRO uses terms from
GO when providing relation information, for example, to
the effect that a given protein or complex has a disposition
toward performing some function during some process
within some cellular location.
PRO meta-structure: sub-ontologies, relations and
categories
PRO encompasses three sub-ontologies: proteins based on
evolutionary relatedness (ProEvo); protein forms
produced from a given gene locus (ProForm); and
protein-containing complexes (ProComp) (Figure 1).
The ProEvo sub-ontology represents proteins translated
from different but related (ortholog or paralog) genes.
The relation used in the ProEvo hierarchy is exclusively
is_a, as in ‘nodal protein is_a TGF-b-like cystine-knot
cytokine’; which is to say that nodal protein is a subtype
of TGF-b-like cystine-knot cytokine.
The ProForm sub-ontology represents all forms of
proteins encoded by a single gene, where ‘all forms’ here
refers to every splice isoform, mutation variant and co- or
post-translationally modiﬁed form (and combinations
thereof) that can arise from translation from that gene
in any organism (see below description of 1:1 ortholog
for what is meant by ‘that gene’). ProForm uses two
relations: is_a denotes the subtype relation between child
and parent term, and derives_from denotes the relation
between a proteolytic cleavage product and its
fully-formed precursor.
The ProComp sub-ontology represents speciﬁc amino
acid chain-containing complexes. The deﬁnition of such
entities is composed by referencing speciﬁc single chain
PRO entries within the ontology (‘complex has_part
subunit’). As for ProForm, there are separate terms for
different versions of a complex, be that difference due to
some change in modiﬁcation status of one or more
components or a change in the identity or stoichiometry
of the components themselves. Thus, a three subunit
complex where one subunit is represented by two
modiﬁed forms will have two separate ProComp terms
that differ only in the form for that one subunit. Like
ProEvo, ProComp uses only the is_a relation in the
hierarchy.
PRO terms are labeled with categories that reﬂect the
overall organization of the ontology. Terms can be labeled
as complexes and as organism-speciﬁc, as appropriate,
and there are several categories used to reﬂect the is_a
hierarchy from ProEvo to ProForm:
Family-level. PRO terms in this category refer to protein
products of a distinct gene family arising from a common
ancestor. The leaf-most nodes at this level are usually
families comprising paralogous sets of gene products
(of one or more organisms). For example, SMAD2 and
SMAD3 both encode proteins belonging to the TGF-b
receptor-regulated smad family, while SMAD1, SMAD5
and SMAD9 are members of the BMP receptor-regulated
smad family. Thus, ‘TGF-b receptor-regulated smad
protein’ and ‘BMP receptor-regulated smad protein’ are
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Figure 1. Overview of PRO. The left panel shows the ProEvo and ProForm subontologies, the right panel shows the ProComp subontology and the
central panel shows the typical resources used to deﬁne or annotate PRO terms.
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category refers to such groupings at any degree of
sequence similarity. For example, the two families
indicated above can be merged into (become subclasses
of) a ‘receptor-regulated smad protein’ class and further
merge (with the protein products of SMAD4, SMAD6
and SMAD7) into a ‘smad protein’ class. Merging
occurs only if the entire, full-length protein is evolution-
arily related. Thus, for example, the smad proteins would
not be found classed with nuclear factor 1 proteins even
though they share one domain (MH1; Pfam:PF03165).
Gene-level. PRO terms in this category refer to the protein
products of a distinct gene. For example, ‘SMAD2’ and
‘SMAD3’ are two different genes, even though they are
paralogs; therefore, they have two different PRO entries at
the gene level of distinction. The protein products of all
alleles of human SMAD2 and mouse SMAD2 thus fall
under this single term. Gene-level distinction is the
leaf-most node of the ProEvo part of PRO.
Sequence-level. PRO terms in this category refer to those
protein products that have a distinct sequence upon initial
translation. The sequence differences can arise from
different alleles of a given gene, from splice variants of a
given RNA, or from alternative initiation and ribosomal
frame-shifting during translation. One can think of this as
a mature mRNA-level distinction. For example, SMAD2
encodes both a long splice form and a short splice form.
The protein products from each isoform are separate PRO
terms. Sequence-level distinction is the ﬁrst (parent-most)
node of the ProForm part of PRO.
Modiﬁcation-level. PRO terms in this category refer to the
protein products derived from a single mRNA species that
differ because of some change (or lack thereof) that occurs
after the initiation of translation (co- or post-
translational). This includes differences due to cleavage
and chemical changes to amino acid residues. For
example, the long isoform of smad2 can either be unmodi-
ﬁed or be post-translationally modiﬁed to contain
phosphorylated residues. Modiﬁcation-level terms are
the leaf-most nodes of the ProForm part of PRO.
1:1 orthologs, orthologous isoforms and orthologous
modiﬁed forms
Each gene-level term in PRO generally includes all trans-
lation products from a given gene in any organism that
contains that gene. That is, a gene-level term in PRO such
as ‘amyloid beta A4 protein’ refers to that same protein in
human, mouse and any other organism that contains an
orthologous gene. The general deﬁnition for gene-level
terms conforms to the format ‘X is a protein that is a
translation product of the X gene or a 1:1 ortholog
thereof.’ The deﬁnition of 1:1 ortholog comes from the
Homology Ontology (HOM) (10), which states that 1:1
orthology ‘...involves two genes that did not experience
any duplication after the speciation event that created
them.’
Special mention must be made of the way in which
speciﬁc isoforms of a given gene are treated in PRO.
PRO considers a protein an isoform when its primary
sequence differs from that of another protein encoded
by the ‘same gene’ in the ‘same organism’ due to alterna-
tive splicing or start site selection (a protein that differs
due to genetic differences is termed ‘sequence variant’).
As for gene-level terms, isoform terms are generally
considered taxon-independent unless otherwise indicated.
How then, can a given isoform term be taxon-independent
(being, as they are, deﬁned in many cases by speciﬁc
sequence)? We deﬁne such orthologous isoforms as
isoforms—encoded by orthologous genes—that are
believed to have arisen prior to speciation and divergence
of the primary sequence. That is, the extant orthologous
isoforms existed as a single isoform in a common ancestor.
Thus if the human and mouse isoforms are deemed to be
orthologous, a single PRO term unifying them is created,
and the database entries providing the sequence for each is
mapped to the single PRO term.
PRO also contains separate entries for speciﬁc modiﬁed
forms of a protein that may exist in multiple organisms.
For example, human c-myc protein (UniProtKB:P01106)
can be phosphorylated at positions 58T, 62S and 71S
(among others) (11). PRO contains explicit entries
for the 62S
phos form, the 58T
phos+62S
phos form and the
62S
phos+71S
phos form. PRO would not contain a
58T
phos+71S
phos form until such is observed.
The 58T
phos+62S
phos form of c-myc includes c-myc in
any organism that contains phosphoresidues correspond-
ing to those indicated. Thus, the PRO term for c-myc
58T
phos+62S
phos includes both human c-myc 58T
phos+
62S
phos and cottontail rabbit c-myc (UniProtKB:
Q9MZT6) 59T
phos+63T
phos, among others.
PRO DATA
Sources and content
PRO information is obtained by manual curation from the
scientiﬁc literature and by large-scale processing of
resources that provide curated protein and pathway infor-
mation. Predominant among these, especially for
gene-level terms in PRO, is UniProtKB. The information
from this resource includes protein name and synonyms
and, indirectly, the deﬁnition. Term name and deﬁnition
follow the conventions used for the human protein. If no
human entry exists, the name is taken from the mouse or
Escherichia coli protein. Indications of initiator methio-
nine removal or signal peptide processing (for example)
also come from this resource. Terms invoking residue
modiﬁcations come from manual curation, or from
other sources that explicitly indicate how multiple
possible modiﬁcations combine. These include Reactome
(12), MouseCyc (13) and EcoCyc (14). These resources
describe both precise proteins forms and precise protein
complexes. Both types of entities are thus being imported
into PRO on a large-scale basis with curator monitoring.
The main sources of terms in the ProEvo sub-ontology are
PIRSF (15) and Panther (16). PRO term deﬁnitions can be
found in the OBO-format ﬁle. Information for each entry
is given in a stanza that provides term ID, name,
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and relationship to other terms.
Annotation
Curators inspect the scientiﬁc literature to ﬁnd references
to protein forms and protein complexes described therein
and to identify associated evidence. Speciﬁc attributes
(such as protein function, localization, process and
involvement in disease) are included in the PRO associ-
ation ﬁle (PAF). All annotations are formulated using
terms from controlled vocabularies [GO, SO, PSI-MOD,
MIM (17), ChEBI, Pfam] and include the corresponding
relation.
Database cross-references
To facilitate navigation from PRO to other resources that
provide information about protein-related entities, we
provide a downloadable tab-delimited list of cross-
references (promapping.txt). The ﬁle explicitly indicates
how the mapped entity relates to the PRO term, where
is_a means that the mapped entity is a subtype of the
PRO entity and ‘exact’ means that they denote the same
entity. Currently the mapping ﬁle contains cross-
references to UniProtKB, HGNC (18), MGI (19),
EcoCyc and Reactome for human, mouse and E. coli
proteins. In the future the mapping will contain all
twelve organisms included in the GO Reference Genome
Annotation project (20).
Data coverage
As stated above, PRO will eventually represent proteins
from the 12 GO Reference Genomes. The number of
possible protein forms within this set is as yet unknown,
but we can make a good estimate of the maximum number
of gene level terms using predicted orthologs from
Inparanoid 7 (21). Out of the nearly 200000 species-
speciﬁc genes, we estimate a total of 100000 gene-level,
1:1 ortholog-based terms. It is similarly not possible to
know how many complexes will eventually be identiﬁed
and represented in PRO, though for example Reactome
has 2700 complexes. Progress toward these goals can be
monitored from the statistics page (http://pir.georgetown
.edu/cgi-bin/pro/sta_pro).
ISSUES CONCERNING PRO DEVELOPMENT
Speed of curating terms
Manual curation is needed to establish a high-quality core
data set and to develop standards for continued growth.
Not surprisingly, proper enumeration of forms, complexes
and variants thereof is laborious, so getting good coverage
and good quality is a challenge. Collaborating with other
resources to capture large blocks of data is one approach
to providing content, and furthermore is a useful frame-
work for developing tools and standards for data import-
ation. We are piloting the use of BioPAX-formatted
pathway information to extract terms for complexes and
protein forms from Reactome, a process which will then
be extensible to other BioPAX-formatted resources.
Data representation
As illustrated by the c-myc example above, orthologous
modiﬁed forms present a challenge for formal representa-
tion because the taxon-speciﬁc children of such terms do
not necessarily share the same sequence or start position.
Such terms therefore cannot be deﬁned by referring to
speciﬁc positions. We currently deﬁne them using free
text and either an example sequence or a motif, but are
exploring ways to formalize these.
COMMUNITY ACCESS
Web access and browsing
The PRO homepage (http://pir.georgetown.edu/pro) is the
starting point for navigation through the PRO resources,
providing both quick and advanced term and annotation
searches, links to associated documents and background
information pages, an ftp download page, term request
and submission pages, and an ontology browser.
Advanced search, quick browse and result pages offer
the ability to reﬁne the output based on predeﬁned
topics that are of special interest to biologists, including
(i) by modiﬁed protein form (any modiﬁcation, or speciﬁc
types, such as phosphorylation or acetylation); (ii) by
complex; (iii) clinical-related terms such as saliva biomark-
ers; or (iv) those with link to an external database.
In addition, Boolean (AND, OR, NOT) searches are sup-
ported, as are ‘null’ (not present) and ‘not null’ (present).
Results are shown in a table format and the columns
displayed can be customized. The table can be saved as
a tab-delimited ﬁle. In addition, PRO terms can be
selected to view the hierarchy in the browser.
The browser displays the structure of the ontology and
overlays information available for displayed terms. It has
the capability to show the complete ontology by clicking
‘Browser’ in the PRO homepage, or to display the
hierarchy for selected terms by selecting PRO terms in
the result table or by selecting the icon next to the PRO
term. Within the Browser page, the ‘ﬁnd’ functionality
displays terms matching a given word or phrase.
In addition, customized data can be displayed by selecting
the speciﬁc tabs (Figure 2).
Clicking on a PRO ID from any page brings up the cor-
responding entry report. The report combines the
information from the ontology ﬁle, the annotation ﬁle
and the mapping ﬁle. It provides a graphical display of
the sequences including modiﬁcations plus links to
external resources (Figure 3). The entry report is divided
into four parts: (i) Ontology information, showing the def-
inition of the protein or complex object, and linking to the
PRO hierarchy for this term. (ii) The representative
proteins for a given protein form with experimental
evidence. Figure 3 shows one example, a proteolytic
cleavage product of isoform 1 of platelet derived growth
factor C. This form is conserved in human and mouse, and
therefore two sequences are displayed along with the
accompanying features; in this case the proteolytic
cleavage product (underlined; region 226–345 in both
organisms). (iii) Mapping to identical objects in an
D542 Nucleic AcidsResearch, 2011, Vol.39, Database issueexternal database. In this example the link is to Reactome,
which has this protein entity because it is involved in a
biological pathway. (iv) The annotation for the particular
protein form (or complex) described in the entry expressed
via relationships to other ontologies and/or databases.
Documentation and data distribution
All documents and data are available from the PRO
website. Documents include information about PRO
annotation guidelines and standards, the description of
the ontological framework, a website tutorial to help
navigate the website and Q&A to address frequent ques-
tions. PRO distribution ﬁles include the ontology in OBO
format (pro.obo), the accompanying annotation ﬁle
(PAF.txt) in a tab delimited format, and mappings to
external databases, also tab delimited.
Integration of PRO within other community database
resources
Links to PRO are available from gene, protein and
pathway databases such as Mouse Genome Inform-
atics (MGI; http://www.informatics.jax.org), MouseCyc
Figure 3. Sample PRO entry report for a cleaved form of platelet-derived growth factor C (partial view). (1) Ontology section, with ID, name and
synonyms, deﬁnition, comments and hierarchy links. (2) Sequence and features for representative entities. For cleaved forms, the underlining
indicates the entity of interest while red letters (not shown in this example) indicate modiﬁed residues. (3) Mapped cross-references to the identical
entity in an external resource. (4) The annotation section.
Figure 2. PRO browser displaying the hierarchy for CD28-containing terms (partial view). (1) The Find box provides a means to display or highlight
terms that match a speciﬁc word or phrase. (2) The hierarchy is displayed with term highlighted. (3) Information tabs: click on a black tab to display
the information in the table (grayed-out tabs either do not apply or have already been selected for display). (4) Customizable table of selected
information. In the example shown Gene, Reactome cross-reference and PMID were selected. Category is shown by default.
Nucleic Acids Research, 2011,Vol.39, Database issue D543(http://mousecyc.jax.org), Reactome (http://www
.reactome.org/) and EcoCyc (http://ecocyc.org), and via
LinkOut from the National Center for Biotechnology
Information (http://www.ncbi.nlm.nih.gov/). PRO serves
as a reference ontology, for example, for the Dendritic
Cell Ontology (22), The Saliva Ontology (23) and the
GO (24).
Submitting and requesting PRO terms
New terms can be requested via the PRO tracker
at http://sourceforge.net/tracker/?func=add&group_id=
266825&atid=1135711. Requests are best submitted by
referring to a UniProtKB accession and providing as
much information as possible, including any relevant
literature citations. Terms can also be submitted via
RACE-PRO (http://pir.georgetown.edu/cgi-bin/pro/race_
pro), a web-based interface that facilitates deﬁning and
annotating protein objects without requiring knowledge
of ontologies or formatting restrictions. The protein
object is deﬁned based on experimental evidence from a
paper describing, for example, some modiﬁcation that
applies to a proteolytic cleavage product. It is then
possible to add annotation using a GO, Pfam, SO or
MIM term. The submitted information is checked and
approved by a PRO editor and converted into the appro-
priate format. The ﬁnal product is sent back to the
submitter for approval.
Linking to PRO
Terms in the PRO and associated information can be
found in all cases using persistent URLs of the form
http://purl.obolibrary.org/obo/PR_xxxxxxxxx where the
x’s represent the numeric portion of the PRO ID.
Interested parties are invited to follow PRO-related
discussions and announcements by joining the PRO
mailing list pro-obo-discuss@lists.sourceforge.net. There
is also a wiki page that presents summary materials and
information about meetings. All pages are accessible from
the PRO home page.
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